Demand for wardrobe, study table, and dining table rentals is increasing across Hyderabad, as urban households reassess the cost of furnishing homes, which can exceed ₹1 lakh when purchased outright. The trend reflects a broader shift toward flexible consumption models in high-mobility residential markets, with platforms such as Rentomojo playing a role in enabling access to essential furniture through subscription-based services. For more information visit https://www.rentomojo.com/hyderabad/furniture-on-rent

Hyderabad’s rapid expansion as a technology and business hub—particularly in areas such as Gachibowli, Hitech City, Kondapur, and the Financial District—has led to a growing population of professionals and students relocating for work and education. Many of these residents operate within tenancy cycles ranging from 11 to 24 months, influencing how they approach home setup decisions.

Establishing a functional home with core furniture categories—including wardrobes, study tables, and dining tables—requires significant upfront investment. Wardrobes typically range from ₹10,000 to ₹30,000, study tables from ₹5,000 to ₹20,000, and dining tables from ₹15,000 to ₹60,000 depending on size and configuration. Beyond purchase costs, ownership involves delivery, installation, ongoing maintenance, and relocation-related expenses.

This cost structure is contributing to a noticeable shift in consumer behavior. Instead of committing capital to ownership, many households are opting for rental models that convert upfront expenditure into predictable monthly payments, often starting at approximately ₹2,000 depending on tenure and configuration. These models enable access to essential furniture without long-term financial commitment.

Mobility remains a central factor driving adoption. In fast-growing residential clusters across Hyderabad, tenants frequently relocate within short timeframes, making ownership of large furniture items less practical. Wardrobes and dining tables, in particular, present logistical challenges related to transport, reinstallation, and wear over repeated moves.

Rental services address these constraints by allowing users to access, upgrade, or return furniture without managing resale or logistics independently. This simplifies relocation and aligns furniture usage more closely with actual duration of stay, which is increasingly variable in urban environments.

Operational efficiency is also influencing adoption. Rental platforms typically provide doorstep delivery and installation within 48 to 72 hours, enabling users to establish functional living spaces quickly after moving. This speed is particularly relevant for professionals relocating on short notice.

Cost predictability is another key advantage cited in the shift toward rentals. Ownership introduces variable expenses over time, including maintenance, repairs, and eventual replacement. Rental models consolidate these into fixed monthly payments, making it easier for households to plan and manage expenses.

Flexibility in tenure further enhances the appeal of these models. Users can align rental periods with lease durations and upgrade or swap products as requirements evolve, particularly in shared housing or co-living arrangements where needs may change frequently.

As the category evolves, consumers are increasingly comparing providers based on pricing transparency, service quality, maintenance coverage, and flexibility. This indicates a maturing market where decision-making is driven by both economic and operational considerations.

Demand is also expanding beyond individual households. Landlords, co-living operators, and property managers are adopting rental solutions to furnish units for tenants without significant upfront investment. This approach enables faster occupancy while reducing the burden of maintenance and replacement.

Service offerings from platforms such as Rentomojo typically include doorstep delivery, installation support, and maintenance during the rental period. Postpaid billing models, refundable security deposits, and flexible tenure options are also commonly associated with these services.

The growth in wardrobe, study table, and dining table rentals across Hyderabad reflects a broader transition toward access-based consumption in urban India. As mobility, cost efficiency, and convenience continue to shape consumer preferences, rental models are becoming an integral part of how homes are furnished and managed.

While ownership remains relevant for long-term residents, increasing adoption of rental solutions highlights a structural change in consumer behavior—one that prioritizes flexibility, liquidity, and alignment with modern urban living patterns. To learn more visit https://www.rentomojo.com/hyderabad

Company information, product details, and service descriptions referenced in this release are based on publicly available materials and official digital channels associated with Rentomojo.

###

For more information about Rentomojo, contact the company here:

Rentomojo
Pratik Vyas
jo@rentomojo.com
Rentomojo
BHIVE Workspace
Kuvempu Nagar,
Bengaluru, Karnataka

CONTACT: Pratik Vyas

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. DailyIndiaNews.com takes no editorial responsibility for the same.

New York, USA, April 30, 2026 (GLOBE NEWSWIRE) — Unlock Epidem Insights Instantly with DelveInsight’s DelveEpiAI: An AI-powered Epidemiology Database for Portfolio, Commercial, and Pipeline Decisions

Answering “how large is our addressable patient pool?” shouldn’t take weeks. DelveInsight’s DelveEpiAI, an AI-driven epidemiology database, delivers validated, analyst-grade insights instantly, so your team can focus on strategy, not data gathering. 

Designed to eliminate the fragmented, time-intensive research that plagues pharmaceutical and healthcare organizations, DelveEpiAI consolidates expert-curated patient population data, incidence/prevalence forecasts, and KOL-validated insights into one intuitive, interactive platform. With coverage spanning 350+ indications across the US, EU4 (Germany, France, Italy, Spain), UK, and Japan, DelveEpiAI equips commercial teams, R&D strategists, and forecasting professionals with the decision-ready epidemiology intelligence they need, precisely when they need it.

The Industry Problem DelveEpiAI Solves

Today, consulting teams and pharmaceutical strategists spend an estimated 60–70% of their time aggregating data rather than generating insights. Epidemiology data remains scattered across PDFs, disconnected journals, and siloed databases, inconsistent in methodology, static in nature, and rarely validated by clinical experts. The result? Blind spots in rare disease markets, unreliable patient population estimates, and commercial strategies built on shaky foundations.

DelveEpiAI directly addresses these gaps by providing:

• A unified platform, no more hunting across multiple sources
• Consistent, validated methodologies across all disease areas
• Real-time querying with AI-assisted exploration, eliminating manual analysis
• KOL- and clinical expert-reviewed insights for trustworthy data
• Forecast-ready datasets built for commercial strategy and portfolio planning

Analyze global disease burden and patient trends faster with DelveEpiAI @ https://www.delveinsight.com/epidemiology-database

What is DelveEpiAI? A Closer Look at the Platform

The DelveInsight epidemiology database is not just a data repository; it is a fully integrated epidemiology intelligence ecosystem. The platform combines AI-driven analytics with expert-curated, KOL-validated data to provide pharmaceutical and healthcare stakeholders with the most comprehensive, transparent, and actionable epidemiology intelligence available in the market today.

Whether you’re sizing a patient population for a rare orphan disease, benchmarking diagnosed prevalence across geographies, or modelling drug-treated patient cohorts by line of therapy, DelveEpiAI gives you answers in minutes, not months.

Layered Intelligence Architecture

The platform is built on a three-layer intelligence framework:

• Data Layer: Structured epidemiology datasets including incidence/prevalence, diagnosed vs. undiagnosed populations, and treated patient pools — ingested from journals, registries, and claims data.
• Analyst & KOL Intelligence: Validated epidemiology models, peer-reviewed literature, and insights from Key Opinion Leaders (KOLs) and clinical registry groups.
• Application Layer: Interactive dashboards and export-ready outputs for seamless use in consulting deliverables, portfolio planning, and market access strategies.

Core Platform Modules

• Disease Overview: Total patient population snapshots and growth trends by indication.
• Epidemiology Trends: Year-wise progression and cross-country comparative analysis.
• Forecast Models: Future disease burden projections through 2034.
• Treated Population Analysis: Identification of treatment-eligible pools, line-of-therapy distribution, biomarker-defined cohorts, and severity segmentation.
• Interactive Analytics: Dynamic filtering by country, year, and patient segment; drill-down into sub-populations; one-click export for presentations.

Request a demo today to power your asset strategy with DelveEpiAI

Key Features of DelveInsight’s Epidemiology Database

• Unmatched Disease Coverage: DelveEpiAI spans a broad range of therapeutic areas, including Oncology, Immunology, Neurology, Respiratory, Dermatology, Ophthalmology, Women’s Health, and Rare Diseases, offering deep epidemiological insight into both high-prevalence conditions and ultra-rare orphan indications.
• 10-Year Epidemiology Forecasts Through 2034: The platform delivers country-specific incidence and prevalence forecasts, enabling pharma teams to model future patient populations, assess market opportunity, and align launch timelines with projected disease burden trends across all 7MM.
• Advanced Epidemiological Segmentation: Go beyond total patient counts. Drill into granular patient segments, including diagnosed prevalent and incident populations, age and gender demographics, biomarker-defined cohorts, disease severity classifications, and line of therapy distribution, all customizable to your indication and geography.
• KOL-Validated, Analyst-Grade Intelligence: Every epidemiology model in DelveEpiAI is built and validated through extensive primary research with leading Key Opinion Leaders (KOLs) and clinical specialists. This ensures that the data you rely on for multi-million dollar decisions meets the highest standards of scientific integrity and clinical relevance.
• Interactive Dashboards for Rapid Insights: DelveEpiAI’s intuitive dashboard interface lets users visualize historical and forecasted patient populations side-by-side, compare trends across geographies, and export data in formats ready for internal forecasting models, dossiers, and board-level presentations.
• Rare & Ultra-Rare Disease Expertise: With an industry-recognized depth in rare and orphan disease epidemiology, DelveInsight provides patient population intelligence that many competitors simply cannot offer, making this database indispensable for companies pursuing niche indications where accurate patient sizing is critically underpinned by regulatory strategy and pricing justification.

Discover smarter epidemiology insights for priority indications @ Healthcare Epidemiology Database

Who Uses DelveEpiAI?

DelveEpiAI is purpose-built for life sciences professionals who require accurate, actionable epidemiology intelligence at scale:

• Pharmaceutical & Biotech Companies: Optimize patient pool selection for drug development, reduce time to forecasting, and align launch strategy with real-world disease burden.
• Commercial Strategy & Market Access Teams: Identify high-value patient segments, uncover untapped treatment markets, and accelerate portfolio planning.
• Epidemiologists & Clinical Researchers: Access validated, KOL-endorsed data models across 500+ indications with full demographic and biomarker segmentation.
• Healthcare Consulting Firms: Reduce manual aggregation time by up to 70% with export-ready datasets and presentation-grade visualizations.
• Public Health Agencies & Investors: Understand disease burden trends and global patient population dynamics across key markets through 2034.

DelveEpiAI vs. Traditional Platforms: A Clear Advantage

While legacy epidemiology platforms deliver static, report-based data requiring significant manual interpretation, DelveEpiAI delivers a fully interactive, AI-native experience. Users move from question to insight in minutes, not days.

Simplify epidemiology analysis with one platform @ Epidemiology Intelligence Platform

Patient Journey Consulting: We deliver a range of distinctive solutions aimed at transforming healthcare experiences. With deep expertise in patient-centric approaches and extensive industry experience, we understand the subtle complexities of patient needs. By leveraging data-driven insights through advanced analytics, we empower healthcare providers to make informed decisions that improve patient outcomes.

Patient Pool Forecasting: DelveInsight recognizes the complexities pharmaceutical and biotech companies face when estimating and selecting the most suitable patient segments for drug development. Making the right choice is crucial for optimizing outcomes while navigating challenges such as determining the appropriate line of therapy, minimizing patient burden, evaluating diagnostic impact, and projecting drug uptake. DelveInsight provides actionable insights and analytics to support these decisions, enabling companies to target patient populations with the greatest unmet needs, thereby enhancing clinical outcomes and streamlining drug development.

Pharma Consulting Services: Our healthcare consulting services turn complex market data into actionable strategies for pharmaceutical, biotech, and medical device companies. We help clients uncover new revenue streams, assess market potential, and successfully navigate commercialization challenges. With deep expertise in clinical trial design, market intelligence, and strategic consulting, our team partners with clients to optimize decision-making, accelerate innovation pipelines, and improve business outcomes.

Rare Disease Consulting Services: In the rare disease space, one of our fortes, we deliver intelligence that helps clients overcome the unique challenges of niche markets. Our analysts monitor global R&D progress, competitive developments, and shifting regulatory landscapes to provide tailored insights that guide product positioning and investment strategies. From in-depth conference evaluations to detailed competitor analyses, we help clients de-risk decision-making, strengthen portfolios, and efficiently advance therapies from development to market.

Ready to drive your pharma research further, faster? Schedule a call with our expert today!

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

CONTACT: Contact Us Shruti Thakur  info@delveinsight.com  +14699457679

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. DailyIndiaNews.com takes no editorial responsibility for the same.

New York, USA, April 30, 2026 (GLOBE NEWSWIRE) — Complement Inhibitors Market Outlook Remains Strong During the Forecast Period (2026–2036) with Increasing Adoption of C5 and C3 Targeted Drugs | DelveInsight

The complement inhibitors market is projected to grow, driven by the rising prevalence of complement-mediated diseases, intensified R&D efforts, and biotechnological advancements enabling novel therapeutic development. Increased awareness among clinicians and the approval of new agents such as ULTOMIRIS [AstraZeneca (Alexion Pharmaceuticals)], Sefaxersen (F. Hoffmann-La Roche/Ionis Pharmaceuticals), KP104 (Kira Pharmaceuticals), Ruxoprubart (NM8074) (NovelMed Therapeutics), Riliprubart (Sanofi), AMY-101 (Amyndas Pharmaceuticals), and others are broadening treatment options, collectively accelerating market expansion.

Recently published Complement Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a comprehensive understanding of current treatment practices, addressable patient population, which includes top indications such as IgA Nephropathy (IgAN), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Paroxysmal Nocturnal Hemoglobinuria (PNH), Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN), Atypical Hemolytic Uremic Syndrome (aHUS), Complement 3 Glomerulopathy (C3G), and others. The selected indications are based on approved therapies and ongoing pipeline activity. The report also provides insights into the emerging complement inhibitors, market share of individual therapies, and current and forecasted market size from 2022 to 2036, segmented into leading markets (the US, EU4, UK, and Japan).

Key Takeaways from the Complement Inhibitors Market Report

• The total complement inhibitors treatment market size is expected to grow positively by 2036 in the leading markets.
• The United States accounts for the largest market size of complement inhibitors, in comparison to EU4 (Germany, Italy, France, and Spain), the UK, and Japan.
• The report provides the total potential number of patients in the indications, such as IgA Nephropathy (IgAN), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Paroxysmal Nocturnal Hemoglobinuria (PNH), Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN), Atypical Hemolytic Uremic Syndrome (aHUS), Complement 3 Glomerulopathy (C3G), and others.
• IgAN reported approximately 135,000 diagnosed prevalent cases in the US. Improved diagnostic practices, greater disease awareness, and wider use of kidney biopsies is expected to drive the growing prevalence of IgAN.
• Leading Complement inhibitor companies, such as AstraZeneca (Alexion Pharmaceuticals), F. Hoffmann-La Roche, Ionis Pharmaceuticals, Arrowhead Pharmaceuticals, Kira Pharmaceuticals, Regeneron Pharmaceuticals, NovelMed Therapeutics, Sanofi, Amyndas Pharmaceuticals, and others, are actively working on innovative complement inhibitors. 
• Some of the key complement inhibitors in clinical trials include ULTOMIRIS (ravulizumab), Sefaxersen (RG6299; IONIS-FB-LRx), ARO-C3, KP104, Pozelimab +  Cemdisiran, Ruxoprubart (NM8074), Riliprubart, AMY-101, and others. These novel complement inhibitors are anticipated to enter the complement inhibitors market in the forecast period and are expected to change the market.

Discover C5 inhibitor market growth projections @ https://www.delveinsight.com/sample-request/complement-inhibitors-market-forecast

Key Factors Driving the Complement Inhibitors Market 

• Rising Prevalence of Complement-Mediated Disorders: Growing diagnosis rates of diseases such as paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), generalized myasthenia gravis (gMG), neuromyelitis optica spectrum disorder (NMOSD), and geographic atrophy are significantly increasing demand for complement-targeted treatments.
• Expanding Approved Indications: Initially focused on ultra-rare hematologic diseases, complement inhibitors are now gaining approvals across neurology, nephrology, and ophthalmology, broadening the addressable patient population and commercial potential.
• Strong Commercial Success of First-Generation Products: The success of therapies such as Eculizumab and Ravulizumab has validated the complement pathway as an attractive therapeutic target, encouraging further investment and pipeline expansion.
• Launch of Emerging Therapies: The dynamics of the complement inhibitors are expected to change in the coming years due to the launch of emerging therapies such as ULTOMIRIS (ravulizumab) [AstraZeneca (Alexion Pharmaceuticals)], Sefaxersen (RG6299; IONIS-FB-LRx) (F. Hoffmann-La Roche/Ionis Pharmaceuticals), ARO-C3 (Arrowhead Pharmaceuticals), KP104 (Kira Pharmaceuticals), Pozelimab +  Cemdisiran (Regeneron Pharmaceuticals), Ruxoprubart (NM8074) (NovelMed Therapeutics), Riliprubart (Sanofi), AMY-101 (Amyndas Pharmaceuticals), and others.

Ramandeep Singh, Senior Consultant of Forecasting at DelveInsight, commented that as newer generations of complement inhibitors target different aspects of the complement cascade (e.g., proximal vs. terminal inhibition), the potential to develop more effective and safer treatments is growing.

Complement Inhibitors Market Analysis

• Complement inhibitor therapies are developed to control overactivation of the complement system, which plays a major role in several immune-mediated disorders. 
• By precisely blocking specific elements of the complement cascade, these treatments help reduce inflammation, prevent tissue injury, and ease disease symptoms, providing a more focused strategy for disease management.
• Within this class, C5 inhibitors such as SOLIRIS and ULTOMIRIS remain the most widely established therapies. 
• SOLIRIS was the first approved agent and works by blocking C5 activation, which prevents membrane attack complex (MAC) formation and reduces hemolysis and thrombotic complications in diseases such as Paroxysmal Nocturnal Hemoglobinuria and Atypical Hemolytic Uremic Syndrome. 
• ULTOMIRIS offers similar efficacy with longer dosing intervals, improving convenience and supporting better adherence.
• SYFOVRE is approved for the treatment of Geographic Atrophy, while EMPAVELI is indicated for Paroxysmal Nocturnal Hemoglobinuria. Both therapies act by targeting abnormal complement activity that contributes to disease progression.
• Although treatment costs remain substantial, SOLIRIS and ULTOMIRIS continue to hold a strong presence in the PNH market because of their proven clinical benefit. Patient assistance initiatives such as Alexion OneSource also help expand treatment access.
• Ongoing research is increasingly directed toward inhibitors of upstream complement targets such as C1 and C3, to treat a broader range of conditions, including Autoimmune Hemolytic Anemia and neuroinflammatory diseases. 
• These next-generation therapies highlight a move toward precision modulation of the complement pathway, creating new possibilities for patients who previously had limited therapeutic choices.

Learn more about the global complement inhibitors CAGR outlook @ Complement Inhibitors Analysis

Complement Inhibitors Competitive Landscape

Some of the complement inhibitors under development include ULTOMIRIS (ravulizumab) [AstraZeneca (Alexion Pharmaceuticals)], Sefaxersen (RG6299; IONIS-FB-LRx) (F. Hoffmann-La Roche/Ionis Pharmaceuticals), ARO-C3 (Arrowhead Pharmaceuticals), KP104 (Kira Pharmaceuticals), Pozelimab +  Cemdisiran (Regeneron Pharmaceuticals), Ruxoprubart (NM8074) (NovelMed Therapeutics), Riliprubart (Sanofi), AMY-101 (Amyndas Pharmaceuticals), and others.

AstraZeneca’s ULTOMIRIS (ravulizumab) is an extended-duration monoclonal antibody designed to block the C5 protein within the terminal complement cascade, enabling rapid, complete, and durable complement inhibition. By acting on this pathway, ULTOMIRIS helps reduce excessive immune system activation that may otherwise harm healthy cells. The therapy is currently under investigation in the Phase III ICAN clinical trial for the treatment of IgAN. It is also covered by patent protection in key global markets, with expected expiry in the United States in 2035 (extendable to 2038), in the European Union through 2035 (with extensions to 2038–2040), and in Japan until 2038.

Roche and Ionis Pharmaceuticals are jointly developing Sefaxersen (RG6299; IONIS-FB-LRx), an antisense oligonucleotide designed to reduce complement factor B gene expression by targeting factor B mRNA. It is the first ASO aimed at selective complement pathway suppression in IgAN. In July 2022, Roche exercised its option to license IONIS-FB-LRx following positive Phase II results. Roche is now responsible for global development, regulatory, and commercialization activities and associated costs, excluding the open-label Phase II study in patients with IgAN, which remains under Ionis’ conduct and funding.

Omeros’ Zaltenibart (OMS906) is a humanized monoclonal antibody designed to inhibit mannan-binding lectin-associated serine protease-3 (MASP-3), a primary activator of the complement alternative pathway. This pathway plays a role in numerous diseases, including conditions addressed by approved and emerging alternative pathway inhibitors. Unlike C3 and C5 inhibitors, blocking MASP-3 does not disrupt the lytic function of the classical complement pathway, which remains essential for the body’s adaptive immune defense against infections.

In a single-ascending-dose Phase I trial involving healthy volunteers, the therapy demonstrated good tolerability with no notable safety concerns. The FDA has granted Orphan Drug Designation (ODD) to Zaltenibart (OMS906) for the treatment of Paroxysmal Nocturnal Hemoglobinuria. At present, two open-label, multicenter clinical studies are underway to assess the drug in adult patients with Paroxysmal Nocturnal Hemoglobinuria.

NovelMed Therapeutics’ Ruxoprubart (NM8074) is an anti-Bb monoclonal antibody designed to selectively inhibit the alternative complement pathway while preserving the classical pathway, which remains essential for infection clearance. In a Phase I study involving 40 healthy volunteers, the therapy demonstrated a favorable safety profile, was well tolerated at all tested dose levels, and achieved complete inhibition of the alternative pathway, with longer inhibition durations observed at higher doses.

The drug is currently being evaluated in a Phase II trial in treatment-naive paroxysmal nocturnal hemoglobinuria (PNH) patients, where early findings appear encouraging. Beyond PNH, Ruxoprubart may also have therapeutic potential in other diseases driven by dysregulation of the alternative complement pathway. The U.S. Food and Drug Administration has authorized Phase Ib/II clinical studies for PNH, C3 Glomerulopathy (C3G), atypical hemolytic uremic syndrome (aHUS), and most recently, ANCA-associated vasculitis (AAV).

Sanofi’s investigational humanized IgG4 monoclonal antibody, Riliprubart, is designed to selectively block activated C1s, a serine protease involved in the classical complement pathway. The therapy is currently in Phase III clinical development for treating Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), particularly in patients who are refractory to standard of care (SoC) treatments or receiving Intravenous Immunoglobulin (IVIg) therapy.

The anticipated launch of these emerging therapies are poised to transform the complement inhibitors market landscape in the coming years. As these cutting-edge therapies continue to mature and gain regulatory approval, they are expected to reshape the complement inhibitors market landscape, offering new standards of care and unlocking opportunities for medical innovation and economic growth.

To know more about who are the leading companies in complement inhibitors, visit @ Complement Inhibitors Treatment 

Recent Developments in the Complement Inhibitors Market

• In April 2026, AstraZeneca reported that its Phase III trial of ULTOMIRIS (ravulizumab) in adults with immunoglobulin A nephropathy (IgAN) successfully achieved its primary endpoint, paving the way for regulatory submissions for the long-acting C5 complement inhibitor in this disease.
• In March 2026, NovelMed Therapeutics Inc. announced two significant milestones in the clinical advancement of Ruxoprubart (NM8074) for the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH).
• In January 2026, Sobi announced that the European Commission (EC) had approved pegcetacoplan for the treatment of adult and adolescent patients aged 12 to 17 years with C3G in combination with a renin-angiotensin system (RAS) inhibitor, unless RAS inhibitor treatment is not tolerated or contraindicated.
• In November 2025, Otsuka received FDA accelerated approval for VOYXACT (sibeprenlimab-szsi) for the reduction of proteinuria in adults with primary IgAN at risk for disease progression.
• In October 2025, Novartis’ FABHALTA (iptacopan) met the Phase III primary endpoint and slowed kidney function decline in patients with IgAN.

What are Complement Inhibitors?

Complement inhibitors are a class of therapeutic agents designed to regulate or block the activity of the complement system, a key component of the innate immune response that helps the body fight infections and clear damaged cells. While essential for normal immunity, uncontrolled or excessive complement activation can lead to inflammation, tissue injury, and the progression of various autoimmune, hematologic, renal, and neurological disorders. Complement inhibitors work by targeting specific proteins within the complement cascade, such as C1s, C3, C5, factor B, or factor D, to prevent downstream inflammatory responses and cell destruction. These therapies have emerged as an important treatment approach for diseases such as paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), myasthenia gravis, geographic atrophy, and other complement-mediated conditions.

Complement Inhibitors Epidemiology Segmentation

The complement inhibitors market report is a comprehensive and specialized analysis, offering in-depth epidemiological insights for the study period 2022–2036 across the leading markets. The complement inhibitor target patient pool is segmented into:

• Total Diagnosed Prevalent Cases of Selected Indication with Complement Inhibitors
• Total Eligible Patient Pool for Complement Inhibitors Targeting Therapies in Selected Indications
• Total Treated Cases for Complement Inhibitors Targeting Therapies in Selected Indications

Scope of the Complement Inhibitors Market Report

• Complement Inhibitors Therapeutic Assessment: Complement Inhibitors current marketed and emerging therapies
• Complement Inhibitors Market Dynamics: Conjoint Analysis of Emerging Complement Inhibitors Drugs
• Competitive Intelligence Analysis: SWOT analysis and Market entry strategies
• Unmet Needs, KOL’s views, Analyst’s views, Complement Inhibitors Market Access and Reimbursement

Discover more about upcoming complement inhibitors in 2026 @ Complement Inhibitors Clinical Trials

Table of Contents

Related Reports

IgA Nephropathy Market Report 

IgA Nephropathy Market Insights, Epidemiology, and Market Forecast – 2036 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key gMG companies, including Novartis, Vertex Pharmaceuticals, Biogen, Vera Therapeutics, AstraZeneca (Alexion Pharmaceuticals), F. Hoffmann-La Roche, Ionis Pharmaceuticals, Takeda Pharmaceutical, Arrowhead Pharmaceuticals, NovelMed, Walden Biosciences, Kira Pharmaceuticals, Purespring Therapeutics, Biohaven Therapeutics, and others.

Complement 3 Glomerulopathy Market

Complement 3 Glomerulopathy Market Insights, Epidemiology, and Market Forecast – 2036 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key C3G companies, including Novartis, Apellis Pharmaceuticals, Sobi, Kira Pharmaceuticals, Novo Nordisk, Omeros Corporation, Arrowhead Pharmaceuticals, and others.

Paroxysmal Nocturnal Hemoglobinuria Market

Paroxysmal Nocturnal Hemoglobinuria Market Insights, Epidemiology, and Market Forecast – 2036 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key PNH companies, including Hoffmann-La Roche, Alexion Pharmaceuticals, Novartis, Regeneron Pharmaceuticals, BioCryst Pharmaceuticals, and others.

Chronic Inflammatory Demyelinating Polyneuropathy Market

Chronic Inflammatory Demyelinating Polyneuropathy Market Insights, Epidemiology, and Market Forecast – 2036 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key CIDP companies, including Sanofi, Janssen Research and Development, LLC, Immunovant Sciences GmbH/HanAll Pharma, Roivant Sciences, Inc., and others.

Immune Complex Membranoproliferative Glomerulonephritis Market

Immune Complex Membranoproliferative Glomerulonephritis Market Insights, Epidemiology, and Market Forecast – 2036 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key IC-MPGN companies, including Novartis Pharmaceuticals, Apellis Pharmaceuticals, and others.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

CONTACT: Contact Us Shruti Thakur  info@delveinsight.com  +14699457679

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. DailyIndiaNews.com takes no editorial responsibility for the same.

Demand for study table, bed, and mattress rentals in Gurgaon is increasing, reflecting a broader shift in how urban professionals approach home setup in high-mobility markets. Platforms such as Rentomojo are witnessing growing adoption as corporate transferees and work-from-home professionals look to avoid upfront setup costs that can range from ₹60,000 to ₹80,000.

Gurgaon, one of India’s primary corporate hubs, continues to attract professionals across consulting, technology, finance, and multinational enterprises. Residential areas including Cyber City, Golf Course Road, and Sohna Road are characterized by frequent tenant turnover, with many residents staying for short to medium durations. This pattern of movement is reshaping consumption behavior, particularly for essential household furniture.

Instead of committing to ownership, a growing segment of residents is prioritizing flexibility and speed when setting up living spaces. The combination of study tables, beds, and mattresses has emerged as a foundational requirement, supporting both productivity and comfort in homes that increasingly serve dual roles as workplaces and living environments.

The financial considerations of ownership remain a key factor. Beds and mattresses alone typically cost between ₹20,000 and ₹60,000 depending on quality and configuration, with study tables adding to the overall expense. Additional costs such as delivery, installation, maintenance, and eventual replacement further increase the total cost of ownership over time.

Rental models offer an alternative by converting these upfront expenses into predictable monthly payments, often starting at approximately ₹1,500 depending on configuration and tenure. This model allows residents to access essential furniture without allocating significant capital at the outset.

Mobility continues to play a central role in this shift. Professionals relocating between cities—or within Gurgaon itself—face logistical challenges when owning large furniture items. Beds often require dismantling and transportation, while mattresses present hygiene and wear concerns, particularly over extended use.

Rental services address these challenges by enabling users to return or transfer products without managing logistics independently. This reduces both the effort and cost associated with relocation, aligning well with the needs of a transient workforce.

Speed of setup is another important factor influencing adoption. Rental platforms typically provide doorstep delivery and installation within a short timeframe, allowing professionals to establish functional living and working environments quickly after moving.

Cost predictability also contributes to the appeal of rentals. Ownership exposes consumers to variable expenses such as repairs and replacements, whereas rental plans provide consistent monthly costs that simplify budgeting and financial planning.

Flexibility in tenure and the ability to upgrade or swap products further support usage in dynamic housing environments. Consumers can align furniture usage with their duration of stay and adapt configurations as their needs evolve, without being locked into long-term ownership commitments.

As the category matures, consumers are increasingly comparing providers based on pricing transparency, service quality, and operational convenience. This reflects a more informed and competitive market, where decision-making is driven by both cost efficiency and user experience.

Beyond individual users, demand is also being driven by co-living operators and property managers who furnish rental units to improve tenant experience. Offering ready-to-use bedroom and workspace setups reduces vacancy time and lowers upfront furnishing costs for property owners.

Service models offered by platforms such as Rentomojo typically include doorstep delivery, installation support, and maintenance during the rental period. Postpaid billing structures, refundable security deposits, and flexible tenure options are also common features within this category.

The increase in study table, bed, and mattress rentals in Gurgaon highlights a broader transition toward access-based consumption in urban India. As professional mobility continues to shape housing patterns, rental models are becoming an integral part of how individuals furnish and experience their homes.

While ownership remains relevant for long-term residents, the growing adoption of rental solutions underscores a structural change in consumer behavior—one that aligns with evolving work patterns, financial priorities, and the realities of modern urban living.

Company information, product details, and service descriptions referenced in this release are based on publicly available materials and official digital channels associated with Rentomojo. To learn more visit https://www.rentomojo.com/

###

For more information about Rentomojo, contact the company here:

Rentomojo
Pratik Vyas
jo@rentomojo.com
Rentomojo
BHIVE Workspace
Kuvempu Nagar,
Bengaluru, Karnataka

CONTACT: Pratik Vyas

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. DailyIndiaNews.com takes no editorial responsibility for the same.

Ottawa, April 30, 2026 (GLOBE NEWSWIRE) — According to Precedence Research, the U.S. dental services market size is valued at USD 185.39 billion in 2026 and is projected to reach nearly USD 281.20 billion by 2035, expanding at a robust CAGR of 4.86% from 2026 to 2035. The in the U.S. dental services market Growth is driven by rising oral health awareness, expanding insurance coverage, aging population needs, and increased adoption of preventive and cosmetic dentistry.

The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report@ https://www.precedenceresearch.com/sample/1425

U.S. Dental Services Market Key Takeaways

• Endodontic procedures held a 26.52% revenue share in 2025.
• Diagnostic and preventive services accounted for 18.97% of revenue in 2025.
• The corrective application segment generated approximately 54.40% of revenue in 2025.

U.S. Dental Services Market Segments Revenue Analysis From 2022 to 2024

U.S. Dental Services Market, By Services, 2022 to 2024 (USD Billion)

U.S. Dental Services Market, By Application, 2022 to 2024 (USD Billion)

➡️ Become a valued research partner with us ☎ https://www.precedenceresearch.com/schedule-meeting

Demand for Dental Services Are Driving Due to Growing Rates of Oral Disease

The U.S. dental services industry continues to grow, driven by the increased number of people with untreated oral disease and the growing awareness of preventive care. The Centers for Disease Control and Prevention states that approximately 21% of adults aged 20-64 years have some form of untreated tooth decay, indicating there is an extensive treatment gap, which contributes to the overall demand for dental services. Around 25% of adults’ ages 20-64 years have at least one unfilled cavity, again demonstrating an urgent need for routine dental care and restorative care.

Recent data collected from 2024 census surveys indicates a high level of untreated decay in children, leading to continued demand for dental service for the entirety of their lifetime. Meanwhile, approximately 64% of the total numbers of non-elderly adults ages 20-64 utilize dental services at least once per year, reflecting a consistent level of demand for dental services and a greater emphasis on preventive care. In addition to the high rates of untreated oral disease, government-supported oral health programs and the growing awareness of the connection between oral health and general health have contributed to the increased demand for dental services in the U.S.

Built for leaders who move markets. Access live, actionable intelligence with Precedence Q. https://www.precedenceresearch.com/precedenceq/

Market Opportunity

In the U.S., the dental services market has many opportunities for growth as a result of under-served populations, a lack of enough dentists, and new technologies. Data from the government shows that almost 57 million Americans live in areas with a shortage of dental care and therefore, there are many opportunities to create new locations and use different types of delivery models like mobile clinics in those locations. There may also be opportunities to add more affordably to address this need because research indicates that about 80% of adults with unmet dental care needs attribute their unmet dental care need to a lack of money, creating opportunities for value-based care and for health insurance.

Furthermore, as oral diseases such as dental decay and gum disease are on the rise in the U.S., the demand for preventative and restorative dental care continues to be increasing. The introduction of new services and technology such as teledentistry, artificial intelligence for diagnosis, and the expansion of the federal workforce support that care can be delivered in an efficient manner and also allows for growth through the expansion to technology-based solutions.

What is Dental Services Market?

The global dental services market is witnessing steady growth, driven by increasing awareness of oral health, rising demand for cosmetic dentistry, and advancements in digital dental technologies. According to Precedence Research, the global dental services market size was valued at approximately USD 499.32 billion in 2025 and is projected to reach around USD 763.74 billion by 2034, expanding at a notable CAGR of 4.85% during the forecast period 2025 to 2034. Growth is supported by an aging population, increasing prevalence of dental disorders, and expanding access to dental care services worldwide. Key segments such as cosmetic dentistry, orthodontics, and preventive care continue to gain traction, while leading companies are focusing on technological innovation and service expansion to strengthen their market presence.

Note: This report is readily available for immediate delivery. We can review it with you in a meeting to ensure data reliability and quality for decision-making.

Try Before You Buy – Get the Sample Report@ https://www.precedenceresearch.com/sample/1301

Dental Services Market Highlights

• By type, dental implants led with a 21% revenue share in 2025, while cosmetic dentistry is projected to grow the fastest from 2025 to 2034.
• By end-use, dental clinics accounted for approximately 69% of the market in 2024.
• North America held a revenue share of about 46% in 2024.
• Asia Pacific is expected to register the highest CAGR between 2024 and 2034.

Get informed with deep-dive intelligence on AI’s market impact https://www.precedenceresearch.com/ai-precedence

U.S. Dental Services Market Insights

➤ Access the Full U.S. Dental Services Market Market Study @ https://www.precedenceresearch.com/us-dental-service-market

Segmental Insights

Services Insights

Why is Endodontic Procedures Dominant Services Segment in 2025?

Endodontic procedures dominate the U.S. dental services market because of the increase in the number of patients with tooth decay and complex root infections that require more specialized forms of treatment and care. Advanced technologies for root canal treatments (like digital imaging, rotary instruments) have improved both treatment outcomes and patient comfort. As well, the increased level of understanding of the importance of preserving your natural teeth through these procedures rather than having them pulled is giving further support to the developing need for endodontic procedures.

Diagnostic and preventive services are experiencing the fastest growth rate of all categories of dental services as a result of more emphasis being put on early diagnosis/detection of dental disease and regular care. Increased public health initiatives and expanded insurance coverage for dental treatment are being utilized to encourage and promote routine dental check-ups and prophylaxes and radiographs to the general public. There is also a growing use of technology (such as AI-based diagnostic programs) and Teledentistry that is being used to make preventative care more accessible for patients and encourage them to use these services more often.

Application Insights

Why Do Corrective is Leading Industry Segment?

The corrective segment is the leading the U.S. dental services market in 2025, as there is a large amount of demand for the treatment of existing dental problems including cavities, misalignment of teeth, and structural deterioration. Generations of people have received dental fillings, crowns, bridges, or orthodontic care. Continued growth of the aging population in addition to being able to afford to pay for cosmetic dental treatments make corrective dental treatments continuously demanded in the US.

The preventive segment is the fastest growing because long-term oral health is being emphasized by both healthcare providers and patients. This market is being positively impacted by initiatives that promote the use of fluoride treatment and sealants and screen patients routinely for potential dental issues. Community programs, schools, and insurers are all encouraging patients to use the dental insurance available to them for preventive dental care because this will save them money in the future for dental treatment, as well as helping patient’s track and maintain oral hygiene via digital health technologies.

✚ Related Topics You May Find Useful:

➡️ Dental Equipment Market: Explore how advanced imaging systems and digital tools are transforming modern dental practices

➡️ Dental 3D Printing Market: Discover how digital dentistry and customized solutions are revolutionizing dental care workflows

➡️ Dental Software Market: Analyze the growing role of AI-driven diagnostics and practice management solutions in dentistry

➡️ Dental Soft Tissue Regeneration Market: Understand advancements in biomaterials and regenerative therapies for improved oral health outcomes

➡️ Oral Care Products and Dental Consumables Market: Gain insights into rising demand for preventive care products and everyday dental essentials

➡️ Dental Acrylic Materials Market: Examine the increasing use of durable and aesthetic materials in prosthetics and restorative dentistry

➡️ Dental Air Polishing System Market: Track innovations in minimally invasive cleaning technologies enhancing patient comfort

➡️ Dental Flap Surgery Market: Learn how surgical advancements are improving treatment outcomes for periodontal diseases

➡️ U.S. Dental Anesthesia Market: Explore the growing need for pain management solutions in complex dental procedures

➡️ Dental Autoclave Market: Understand the importance of sterilization technologies in ensuring patient safety and regulatory compliance

U.S. Dental Services Market – Value Chain Overview

Dental Product & Equipment Manufacturing: The value chain begins with the production of essential dental materials, tools, and technologies such as restorative materials, implants, imaging systems, CAD/CAM solutions, and dental chairs that enable modern clinical care.
Key players: Dentsply Sirona, 3M Oral Care, Align Technology, Envista Holdings, Straumann Group, Planmeca, Ivoclar Vivadent, GC Corporation, Carestream Dental.

Supply & Distribution Networks: Distributors play a critical role in delivering dental products, instruments, and consumables to clinics and labs while also supporting software integration and practice management systems.
Key players: Henry Schein Inc., Patterson Companies, Benco Dental, Burkhart Dental Supply, Darby Dental Supply.

Dental Practice Management & Support Organizations:Dental Support Organizations (DSOs) and networks assist practices with non-clinical functions like HR, finance, procurement, marketing, and regulatory compliance, improving efficiency and scalability.
Key players: Heartland Dental, Aspen Dental Management Inc., Pacific Dental Services, Smile Brands, Western Dental & Orthodontics, DentalCorp.

Clinical Service Delivery: Dental clinics and specialists form the core of the ecosystem, offering preventive, restorative, cosmetic, and surgical treatments through general and specialized care providers such as orthodontists and oral surgeons.
Key participants: Independent clinics, DSO-affiliated practices, university hospitals, and specialty centers.

Digital Technology, Diagnostics & AI Integration: Advanced technologies such as digital imaging, AI-driven diagnostics, intraoral scanning, 3D printing, and tele-dentistry are transforming workflows, improving accuracy, and enhancing patient outcomes.
Key innovators: Align Technology, Dentsply Sirona, Philips Oral Healthcare, Formlabs Dental, Carbon, SprintRay, Pearl AI, Overjet, Planmeca Digital.

Insurance, Financing & Reimbursement: Insurance companies and third-party payers expand patient access through coverage plans, financing options, and reimbursement systems, influencing affordability and service utilization.
Key players: Delta Dental, DentaQuest, MetLife Dental, Aetna Dental, Cigna Dental, UnitedHealthcare Dental, Guardian Life.

Education, Training & Research Institutions: Dental schools, research bodies, and professional associations support workforce development, clinical innovation, and evidence-based standards across the industry.
Key institutions: American Dental Association (ADA), ADA Health Policy Institute, American Dental Education Association (ADEA), National Institute of Dental and Craniofacial Research (NIDCR), Harvard School of Dental Medicine, UCSF School of Dentistry, NYU College of Dentistry.

Competitive Landscape

• Smile Brands Inc.
• Aspen Dental
• InterDent (Gentle Dental)
• Coast Dental
• Pacific Dental Services
• Heartland Dental
• Affordable Care
• Great Expressions Dental Centers
• Western Dental
• Dental Care Alliance

What are the Major Developments in the U.S. Dental Services Market?

• In February 2026, VideaHealth partnered with Aspen Dental to deploy AI-powered diagnostic tools across 1,100 clinics in six weeks, enhancing early disease detection, treatment planning consistency, and patient communication nationwide. (Source – https://www.businesswire.com)
• In February 2025, Colgate-Palmolive introduced the Colgate Total Active Prevention System, combining toothpaste, toothbrush, and mouthwash with advanced stannous fluoride technology to reduce bacteria, cavities, and gingivitis through a preventive, science-backed oral care routine. (Source – https://www.nbcnews.com)
• In May 2025, Pearl received FDA clearance for its Second Opinion® 3D platform, becoming the first dental AI provider supporting both 2D and 3D imaging, enabling faster, more accurate diagnostics and improved treatment planning using CBCT scans. (Source- https://hellopearl.com)

Segments Covered in the Report

By Services

• Cosmetic Dentistry
• Endodontic Procedures
• Periodontal Dentistry
• Orthodontic and Periodontic Services
• Diagnostic and Preventive Services
• Oral and Maxillofacial Surgery

By Application

• Preventive
• Corrective
• Therapeutic

By Geography

• North America
• Asia Pacific
• Europe
• Latin America
• Middle East & Africa

Thank you for reading. You can also get individual chapter-wise sections or region-wise report versions, such as North America, Europe, or Asia Pacific.

Immediate Delivery Available | Buy This Premium Research Report@ https://www.precedenceresearch.com/checkout/1425

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 804 441 9344

Stay Ahead with Precedence Research Subscriptions

Unlock exclusive access to powerful market intelligence, real-time data, and forward-looking insights, tailored to your business. From trend tracking to competitive analysis, our subscription plans keep you informed, agile, and ahead of the curve.

Browse Our Subscription Plans@ https://www.precedenceresearch.com/get-a-subscription

About Us

Precedence Research is a worldwide market research and consulting organization. We give an unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

Web: https://www.precedenceresearch.com

Our Trusted Data Partners:

Towards Healthcare | Towards Packaging | Towards Chem and Materials | Towards FnB | Statifacts | Nova One Advisor | Market Stats Insight

Get Recent News:

https://www.precedenceresearch.com/news

For the Latest Update Follow Us:

LinkedIn | Medium | Facebook | Twitter

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. DailyIndiaNews.com takes no editorial responsibility for the same.

Austin, United States, April 30, 2026 (GLOBE NEWSWIRE) — According to SNS Insider, the Medical Rehabilitation Services Market size was valued at USD 270.59 billion in 2025 and is projected to surpass USD 574.25 billion by 2035, growing at a CAGR of 7.08% from 2026-2035. The increased prevalence of chronic illnesses, age-related mobility limitations, and long-term disabilities that require therapy and recovery support are driving growth in the medical rehabilitation services market.

Medical Rehabilitation Services Market Size & Forecast

• Market Size (2025): USD 270.59 Billion
• Projected Market Size (2035): USD 574.25 Billion
• CAGR (2026–2035): 7.08%
• Forecast Period: 2026–2035
• Base Year: 2025

Get a Sample Report of Medical Rehabilitation Services Market: https://www.snsinsider.com/sample-request/9219

The U.S. Medical Rehabilitation Services Market was valued at USD 84.03 Billion in 2025 and is expected to reach USD 169.91 Billion by 2035, growing at a CAGR of 6.61% from 2026-2035. The market is still being driven in all medical settings by rising rates of neurological, occupational, and physical disorders as well as improvements in therapy technologies and improved insurance coverage.

Rising Demand for Advanced Regenerative Therapies to Augment Market Expansion Globally

Demand for biomimetic materials is rising dramatically due to the expanding emphasis on regenerative medicine, which is motivated by the need to replace or repair damaged tissues. Better integration, quicker healing profiles, and fewer rejection rates are made possible by materials that closely mimic the structure and behavior of natural tissue. Biomimetic technologies provide better outcomes in orthopaedics, cardiology, dentistry, and wound care in response to patient and physician demand for better alternatives to conventional implants. Tissue engineering and advanced biomaterials research are two other uses of biomimetics in the field of next-generation regenerative therapeutics.

Major Medical Rehabilitation Services Market Companies Listed in the Report are

• Select Medical Holdings Corp.
• Encompass Health Corporation
• Kindred Rehabilitation Services
• U.S. Physical Therapy, Inc.
• Shirley Ryan AbilityLab
• Nuffield Health
• ATI Physical Therapy (ATI Holdings)
• Athletico Physical Therapy
• Bupa Rehabilitation
• UpHealth Inc. (TeleRehab)
• Prism Medical
• Icahn School of Medicine at Mount Sinai (Rehab Division)
• Kessler Institute for Rehabilitation
• The University of Chicago Medical Center (Rehab Services)
• MindMaze Healthcare
• Lifespan Physical Therapy Services
• SuVitas
• nMotion Physical Therapy
• Therapy Solutions Children’s Services, Inc.
• SuVitas

Segmentation Analysis:

By Setting

Outpatient segment dominated the Medical Rehabilitation Services Market with the highest revenue share of about 54% in 2025 due to its cost-effectiveness, convenience, and higher patient preference globally. Inpatient segment is expected to grow at the fastest CAGR from 2026-2035 due to rising demand for intensive rehabilitation for severe neurological, trauma, and post-surgical cases.

By Therapy

Physical Therapy segment dominated the Medical Rehabilitation Services Market with the highest revenue share of about 37% in 2025 due to its broad applicability across musculoskeletal, neurological, and post-surgical conditions. Cognitive Therapy segment is expected to grow at the fastest CAGR from 2026-2035 driven by rising cases of mental health disorders, and post stroke cognitive impairments.

By Application

Orthopedic segment dominated the Medical Rehabilitation Services Market with the highest revenue share of about 37% in 2025 due to the rising incidence of fractures, joint disorders, arthritis and post-operative orthopedic rehabilitation needs globally. Sports Related Injuries segment is expected to grow at the fastest CAGR from 2026-2035 owing to increasing sports participation, higher injury rates among youth and professional athletes.

By End-Use

Hospitals & Clinics segment dominated the Medical Rehabilitation Services Market with the highest revenue share of about 31% in 2025 due to strong referral networks globally.  Rehab Centers segment is expected to grow at the fastest CAGR from 2026-2035 due to increasing need of specialized, long-term and condition-specific rehabilitation globally.

Do you have any specific queries or need any customization research on Medical Rehabilitation Services Market, make an Enquiry Now: https://www.snsinsider.com/enquiry/9219

Medical Rehabilitation Services Market Key Segments

By Therapy

• Physical Therapy
• Occupational Therapy
• Cognitive Therapy
• Speech and Language Therapy
• Others

By Application

• Orthopedic
• Cardiologic
• Neurological
• Pulmonary
• Sports Related Injuries
• Others

By Setting

• Outpatient
• Inpatient

By End-use

• Hospital and Clinics
• Rehab Centers
• Homecare Settings
• Physiotherapy Centers

Regional Insights:

Due to its well-established healthcare infrastructure, abundance of specialized rehab facilities, robust insurance coverage, and sizable population with chronic illnesses, age-related mobility disorders, and post-surgical rehabilitation needs, North America dominated the Medical Rehabilitation Services Market in 2025 with a roughly 38% revenue share.

From 2026 to 2035, Asia Pacific is predicted to develop at the fastest compound annual growth rate (CAGR) of roughly 9.04%. This growth will be fueled by the region’s rapid healthcare modernization, rising prevalence of chronic diseases, growing medical tourism, and growing awareness of rehabilitation services.

Recent Developments:

• May 2024, UChicago Medicine opened a new 132,000-square-foot multispecialty care center in Crown Point, Indiana. The facility expands access to advanced outpatient and specialty services for regional patients. It supports integrated care by combining diagnostics, clinical programs, and rehabilitation services under one roof.
• August 2025, Encompass Health entered a joint venture with BSA Health System to establish a new 50-bed inpatient rehabilitation hospital in Amarillo, Texas. The facility will expand access to advanced rehabilitation services, including stroke, neurological, and orthopedic recovery programs.

Exclusive Sections of the Report (The USPs):

• PATIENT DEMOGRAPHICS & UTILIZATION METRICS – helps you understand patient distribution, therapy usage trends, and demand driven by chronic conditions and rehabilitation needs.
• DISEASE BURDEN & REHABILITATION DEMAND INSIGHTS – helps you evaluate incidence of injuries, neurological disorders, and NCDs along with their impact on rehabilitation services demand.
• INSURANCE & REIMBURSEMENT ANALYSIS – helps you assess coverage trends, reimbursement rates, and out-of-pocket expenditure influencing access to rehabilitation services.
• INFRASTRUCTURE & CAPACITY METRICS – helps you analyze availability of rehabilitation centers, hospital capacity, and therapist-to-patient ratios across regions.
• TECHNOLOGY ADOPTION & ADVANCED REHAB TRENDS – helps you track the adoption of robotic and tech-enabled rehabilitation systems improving treatment efficiency and outcomes.

Buy an Enterprise-User PDF of Medical Rehabilitation Services Market Outlook Report 2026-2035: https://www.snsinsider.com/checkout/9219

Medical Rehabilitation Services Market Report Scope

Related Market Reports

Neurorehabilitation Market

Rehabilitation Robots Market

Telerehabilitation Market

Physical Therapy Software Market

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

CONTACT: Contact Us: Rohan Jadhav - Principal Consultant Phone: +1-315-961-9094 (US) Email: info@snsinsider.com 

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. DailyIndiaNews.com takes no editorial responsibility for the same.

Aviation fuel producers focus on developing high-quality fuels that enhance the aircraft’s performance and reduce operational costs associated with air travel. The increasing focus on reducing the impact of aviation emissions on the environment has increased the investment in sustainable aviation fuels. Aviation fuel producers play a pivotal role in providing efficient and environmentally responsible fuel to the global aviation industry. Advancements and the availability of various fuel-producing techniques are also contributing to the aviation fuel market.

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231148230

Major Key Players in the Aviation Fuel Industry:

• Exxon Mobil Corporation (US),
• Chevron Corporation (US),
• BP plc (UK),
• Shell (UK), and
• TotalEnergies (France)

Aviation Fuel Market Segmentation:

By aircraft type, the fixed-wing aircraft segment of the aviation fuel market is projected to register the largest market share during the forecast period.

The fixed-wing aircraft segment is projected to hold the largest share in the aviation fuel market during the forecast period, driven by the rising global demand for commercial air travel, cargo transportation, and defense operations. Fixed-wing aircraft, including passenger jets, cargo planes, and business jets, consume significant volumes of jet fuel and aviation turbine fuel (ATF) due to their higher operational range and longer flight durations compared to rotary-wing or UAV platforms. The ongoing fleet expansion by major airlines and the recovery of international flight routes post-pandemic are further fueling the segment’s growth.

By fuel type, the conventional fuel segment is projected to dominate the market.

Based on fuel type, the conventional fuel segment is expected to dominate the market as the primary and most reliable source of aviation energy. Jet A and Jet A-1 remain the industry standards due to their wide availability, energy density, and cost-effectiveness. Although sustainable aviation fuel (SAF) is gaining momentum, conventional fuels still account for the majority of global aviation operations, supported by established refining, storage, and distribution networks. The combination of growing air passenger traffic and the robust infrastructure supporting traditional fuel supply ensures the continued dominance of conventional aviation fuels during the forecast period.

Asia Pacific is expected to register the largest market share during the forecast period.

The Asia Pacific is projected to register the largest market for aviation fuel during the forecast period. Increasing air travel demands, both regional and international, are fueling the demand for aviation fuel in the region. Also, governments and the aviation industry players in the region are actively investing in the production of SAF innovations. The key hubs in Singapore continue to dominate as the global transit points, while in emerging markets, there is rapid construction of airports and expansion of fleets to take care of more passenger traffic. This growth directly correlates with higher consumption of aviation fuel, thereby increasing the Asia Pacific market share.

Ask for Sample Report:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=231148230

Key Takeaways:

• The Asia Pacific aviation fuel market is estimated to account for a 33.5% market share in 2025.
• By fuel type, the sustainable aviation fuel segment is projected to register a higher CAGR (59.9%) than the sustainable aviation fuel segment during the forecast period.
• By aircraft type, the unmanned aerial vehicle segment is projected to grow at the highest rate during the forecast period.
• By end user, the airline segment is projected to dominate the market during the forecast period.
• Major players, such as Exxon Mobil Corporation (US) and Shell (UK), have adopted organic and inorganic strategies, including partnerships and investments, to grow in the aviation fuel market.
• Companies Prometheus Fuels, SKYNRG, and Air Company, among others, have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.

See More Latest Aerospace Industry Reports:

Sustainable Aviation Fuel Market by Fuel Type (Biofuel, Hydrogen Fuel Cell, Power to Liquid, Gas to Liquid), Biofuel Manufacturing Technology, Blending Capacity (Below 30%, 30% to 50%, Above 50%), Platform and Region – Global Forecast to 2030

Urban Air Mobility Market by Mobility Type (Air Taxi, Personal Air Vehicle, Cargo Air Vehicle, Air Shuttles & Metros), Solution (Platform, Charging, Vertiport), Platform Architecture (Multicopters, Lift + Cruise), Range & Region – Global Forecast to 2035

CONTACT: About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook . Contact: Mr. Rohan Salgarkar MarketsandMarkets™ INC. 1615 South Congress Ave. Suite 103, Delray Beach, FL 33445 USA: +1-888-600-6441 Email: sales@marketsandmarkets.com Visit Our Website: https://www.marketsandmarkets.com/

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. DailyIndiaNews.com takes no editorial responsibility for the same.

Austin, United States, April 30, 2026 (GLOBE NEWSWIRE) — The global Point-of-Care (POC) Diagnostics Market was valued at USD 54.50 billion in 2025 and is projected to reach USD 114.65 billion by 2035, expanding at a CAGR of 7.72% during 2026–2035. The market is largely driven by the increasing demand for speedy accurate and point-of-care diagnostic methods.

In point-of-care testing, a sample is gathered and tested at or near the location where the patient is receiving care, drastically reducing the time it takes to try them using a centralized laboratory system. Their performance is being improved through continuing research into aspects such as biosensors, microfluidic chips and AI-driven analysis.

Point-of-Care Diagnostics Market Size & Forecast

• Market Size (2025): USD 54.50 Billion
• Projected Market Size (2035): USD 114.65 Billion
• CAGR (2026–2035): 7.72%
• Forecast Period: 2026–2035
• Base Year: 2025

Get a Sample Report of Point-of-Care Diagnostics Market: https://www.snsinsider.com/sample-request/5572

The U.S. Point-of-Care Diagnostics industry was valued at USD 23.44 Billion in 2025 and it is expected to reach USD 49.30 Billion by 2035, growing at a CAGR of 7.72% during the forecast period of 2025-2035. This dominance is due to the healthcare system and healthcare expenditure in the country and chronic diseases like diabetes and heart diseases.

In addition, regulatory backing, such as CLIA-waived tests and FDA’s regulatory framework, continues to boost the adoption rate of innovative diagnostics. In addition, the growing consumer awareness and demand for home diagnostics drive the growth of the market.

Rising Burden of Chronic and Infectious Diseases

The rising number of cases of chronic diseases such as diabetes, cardiovascular diseases, chronic kidney diseases, and respiratory disorders is one of the major factors driving the growth of this market. As an alternative, infectious diseases like influenza, HIV, tuberculosis, and emerging pathogens also need rapid and they continue to need good diagnostic.

POC diagnostics provide rapid, cost-effective, and accessible testing strategies that are available in last mile clinical and non-clinical settings. Meanwhile, the COVID-19 pandemic only sped the additional spread of and penchant for decentralized testing and provided sustainable, long-term exertion for rapid worldwide diagnostics.

Segment Analysis

By Product: Blood Glucose Monitoring Dominates; Molecular Diagnostics Fastest Growing

Blood glucose monitoring held over 54% of the market share, due to the growing diabetic patient population across the globe, which has now exceeded 537 million adults. The ultra-thin wearable CGM devices that can be used on smartphones are changing the diabetes care landscape. The molecular diagnostics segment is projected to grow at the highest CAGR owing to advancements in isothermal amplification, lab-on-a-chip, and microfluidic technologies.

By Sample Type: Blood Leads; Urine Gains Momentum

Blood-based testing are expected to remain dominant throughout the markets, due to their diagnostic accuracy, and the large scope of their applicability to treatment of various diseases. They are essentiel in the event of emergency and critical situations.

Urine-based diagnostics are expected to grow at the highest CAGR due to their non-invasiveness and precision in use along with rising applications in CKD, UTIs, and metabolic disorder detection.

By End User: Hospitals Lead; Home Care Expands Rapidly

Hospitals occupied the highest market share in 2025 because of the large number of patients, infrastructure development, and need for bedside diagnosis in emergency situations. However, Home care is the fastest growing segment, owing to increased awareness among consumers, availability of self-test kits, and move towards patient-centric healthcare. There has been an increase in demand for at-home testing kits for diabetes, infections, and chronic diseases.

Do you have any specific queries or need any customization research on Point-of-Care Diagnostics Market, make an Enquiry Now: https://www.snsinsider.com/enquiry/5572

Regional Insights

North America dominated the market with more than 43% share in 2025, owing to the presence of robust healthcare infrastructure and high spending on diagnosis and advanced technology. Moreover, the support from companies such as Abbott, Roche, Siemens Healthineers, and, Becton Dickinson also aids the market growth.

The expected growth in the Asia-Pacific region will be robust at approximately 8.97% CAGR. Factors responsible for this include an increase in health expenditure, the rise in hospitals and hospital centres and high incidence of the chronic and communicable disease. For nations like China and India, they need novel and low-cost diagnostic products that are easy to transport.

Major Point-of-Care Diagnostics Market Companies Listed in the Report are

• Abbott Laboratories
• F. Hoffmann-La Roche Ltd.
• Siemens Healthineers
• Danaher Corporation (Cepheid, Radiometer)
• Becton Dickinson and Company
• Thermo Fisher Scientific
• Quidel Corporation (QuidelOrtho)
• bioMérieux SA
• Chembio Diagnostics
• Alere Inc.
• Binax
• OraSure Technologies
• Nova Biomedical
• Mindray Medical International
• i-STAT
• Boehringer Ingelheim
• Nihon Kohden Corporation
• Sekisui Diagnostics
• Polymer Technology Systems
• LumiraDx

Point-of-Care Diagnostics Market Key Segments

By Product

• Blood Glucose Monitoring
• Infectious Disease Monitoring
• Cardiometabolic Disease Testing
• Hematology Testing
• Others

By Sample

• Blood
• Nasal and Oropharyngeal Swabs
• Urine
• Others

By End- User

• Hospital Bedside
• Physican’s Office Lab
• Urgent Care & Retail Clinics
• Home & Self Testing

Buy an Enterprise-User PDF of Point-of-Care Diagnostics Market Outlook Report 2026-2035: https://www.snsinsider.com/checkout/5572

Point-of-Care Diagnostics Market Report Scope

Related Market Reports

Point-of-Care Molecular Diagnostics Market

Point-of-Care Ultrasound Market

Point of Care Diagnostics/Testing Market

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

CONTACT: Contact Us: Rohan Jadhav - Principal Consultant Phone: +1-315-961-9094 (US) Email: info@snsinsider.com 

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. DailyIndiaNews.com takes no editorial responsibility for the same.

Austin, April 30, 2026 (GLOBE NEWSWIRE) — The Feed Binders Market was valued at USD 4.96 billion in 2025 and is expected to reach USD 7.48 billion by 2035, growing at a CAGR of 4.20% over the forecast period.

The market for feed binders is expanding as a result of increased demand for better feed stability and premium animal nutrition on a global scale. Effective binders that improve feed durability and palatability are becoming more and more necessary as animal production rises due to the growth of the meat, dairy, and aquaculture industries.

Download PDF Sample of Feed Binders Market @ https://www.snsinsider.com/sample-request/9226 

U.S. Feed Binders Market was valued at USD 0.89 billion in 2025 and is expected to reach USD 1.28 billion by 2035, growing at a CAGR of 3.74% from 2026 to 2035.

Rising livestock production and the need for premium, nutritionally stable animal feed is driving growth in the U.S. feed binders market. Market expansion in the poultry, livestock, and aquaculture industries is being further supported by stricter feed safety standards and a move toward natural and sustainable binder ingredients.

Rising Demand for High-quality Animal Feed to Augment Market Expansion Globally

Premium-quality feed is becoming more and more in demand as livestock producers concentrate on increasing animal nutrition and production. In order to improve pellet durability, prevent breakage during handling, and guarantee constant nutritional intake, feed binders are essential. They are crucial to contemporary feed composition because of their capacity to increase overall efficiency, decrease dust, and improve feed texture. Feed binders are becoming more widely used in the production of feed for poultry, cattle, aquaculture, and swine due to the increased focus on optimizing feed conversion ratios and preserving product quality throughout supply chains.

Segmentation Analysis:

By Source

Natural Binders segment dominated the Feed Binders Market with the highest revenue share of about 62% in 2025 and is expected to grow at the fastest CAGR from 2026-2035 due to increasing preference for safe, sustainable, and eco-friendly feed components.

By Livestock

Poultry segment dominated the Feed Binders Market with the highest revenue share of about 41% in 2025 due to rising global poultry consumption and increasing commercial poultry farming. Aquaculture segment is expected to grow at the fastest CAGR from 2026-2035 driven by expansion of fish and shrimp farming globally.

By Product Type

Lignosulfonates segment dominated the Feed Binders Market with the highest revenue share of about 30% in 2025 due to their cost-effectiveness and strong binding capability globally. Synthetic Binders segment is expected to grow at the fastest CAGR from 2026-2035 due to increasing adoption of high-performance globally.

By Application

Pelleting & Processing Efficiency segment dominated the Feed Binders Market with the highest revenue share of about 38% in 2025 due to the growing need for improved pellet strength globally. Feed Stability & Durability segment is expected to grow at the fastest CAGR from 2026-2035 driven by rising focus on high-quality pellets that maintain integrity during storage globally.

If You Need Any Customization on Feed Binders Market Report, Inquire Now @ https://www.snsinsider.com/enquiry/9226 

Regional Insights:

With a 31% revenue share in 2025, Asia Pacific dominated the feed binders market. Due to growing livestock output, rising meat consumption, and growing demand for premium compound feed, the region is expected to develop at the quickest CAGR of 5.62% between 2026 and 2035.

North America captured a significant share of the Feed Binders Market in 2025 due to strong industrial livestock farming, high adoption of compound feed, and stringent quality standards promoting the use of efficient binding agents. 

Major Key Players:

• Darling Ingredients Inc.
• Archer Daniels Midland (ADM)
• DuPont de Nemours, Inc.
• BASF SE
• Roquette Frères
• Borregaard ASA
• CP Kelco, Inc.
• Cra-Vac Industries, Inc.
• Beneo GmbH
• Kemin Industries, Inc.
• Alltech
• Visco Starch
• Bentoli AgriNutrition Pvt. Ltd.
• Uniscope, Inc.
• Allwyn Chem Industries
• Royal Avebe U.A.
• FMC Corporation
• Gelita AG
• Ingredion Incorporated
• Kalsec Inc.

Recent Developments:

2025, Darling Ingredients Inc. launched Nextida, a collagen- and gelatin-based health and nutrition platform, expanding its specialty proteins portfolio for food, feed, and wellness applications while reinforcing its circular, sustainable ingredient strategy. 

2025, Archer Daniels Midland introduced Digest Carb, a synergistic ruminant feed solution launched at SPACE 2025 in Europe to enhance fiber degradability, milk yield, feed efficiency, and sustainability for dairy producers.

Buy Full Research Report on Feed Binders Market 2026-2035 @ https://www.snsinsider.com/checkout/9226 

Exclusive Sections of the Report (The USPs):

• Livestock Feed Utilization & Binder Demand Metrics – helps you understand binder consumption patterns across livestock segments, inclusion rates in feed formulations, and demand driven by compound feed production.
• Raw Material Availability & Pricing Insights – helps you evaluate production volumes, price volatility, and supply–demand gaps of key binder ingredients along with dependency on imports.
• Quality & Performance Efficiency Metrics – helps you assess binder effectiveness through pellet durability, reduction in fines, moisture retention, and impact on feed conversion ratio and digestibility.
• Feed Format & Application Analysis – helps you identify adoption trends of binders in pellet vs. mash feed formats and their role in improving feed stability and handling.
• Regulatory & Compliance Landscape – helps you understand approval rates, restrictions on synthetic binders, and trends in organic, non-GMO, and antibiotic-free feed production.

Read Other Related Reports:

Feed Mycotoxin Detoxifiers Market

Feed Flavors and Sweeteners Market

Feed Mixer Market

Aquafeed Additives Market

Microbial Products Market

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

CONTACT: Rohan Jadhav - Principal Consultant Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. DailyIndiaNews.com takes no editorial responsibility for the same.

Health Awareness and Dietary Shifts Driving Demand

• Rising prevalence of celiac disease and gluten intolerance is increasing the need for gluten-free alternatives
• Growing adoption of gluten-free diets as part of a healthier lifestyle
• Increasing demand for clean-label, allergen-free, and nutritionally balanced food products
• Expanding consumer base beyond medical necessity to wellness-focused individuals

Request Custom Data to Address your Specific Business Needs

Product Innovation Expanding Market Opportunities

Innovation is playing a crucial role in shaping the gluten-free products market. Manufacturers are developing a wide range of products including bakery items, snacks, ready-to-eat meals, pizzas, and pastas.

Companies such as The Kraft Heinz Company and The Hain Celestial Group are actively launching new gluten-free offerings that combine taste, convenience, and nutritional value. These innovations are helping bridge the gap between traditional and gluten-free food experiences.

Specialty Stores Enhancing Product Accessibility

• Specialty stores offer curated selections and expert guidance for consumers with dietary needs
• Higher consumer trust due to product quality and specialization
• Bakery, gourmet, and health stores providing customized and premium gluten-free options
• Retailers like Whole Foods Market expanding gluten-free product availability

Pizzas and Pastas Segment Maintaining Strong Demand

The pizzas and pastas segment holds a substantial share in the gluten-free market, driven by consumer preference for familiar and convenient meal options. Gluten-free versions of these products allow consumers to enjoy traditional dishes without compromising their dietary needs.

Major players such as Conagra Brands, Inc. and Barilla G. e R. Fratelli S.p.A. are expanding their product lines to meet increasing demand in this segment.

Italy Leading the European Gluten-Free Market

Italy is expected to maintain a dominant position in the European gluten-free products market. The country’s strong food culture, high awareness of gluten intolerance, and demand from international tourists contribute to its leadership.

Key companies such as Dr. Schär AG / SPA and Fiorino S.p.A. are driving innovation and maintaining high-quality standards in gluten-free product manufacturing.

Make an Inquiry to Address your Specific Business Needs

Competitive Landscape and Key Players

The gluten-free products market is highly competitive, with several global companies focusing on innovation, quality, and expansion. Leading players include The Kraft Heinz Company (US), The Hain Celestial Group (US), General Mills, Inc. (US), Conagra Brands, Inc. (US), Kellanova (US), Barilla G. e R. Fratelli S.p.A. (Italy), Raisio Oyj (Finland), Dr. Schär AG / SPA (Italy), Ecovia, Enjoy Life (US), Alara Wholefoods Ltd (England), Katz Gluten Free (US), Genius Foods (UK), Silly Yaks – For Real Taste (Australia), and Norside Foods Ltd. (UK).

These gluten-free products companies leverage advanced production technologies, strict allergen control measures, and strong distribution networks to meet the growing global demand.

Future Outlook

The future of the gluten-free products market remains promising, supported by continuous product innovation, increasing health awareness, and expanding distribution channels. As consumer preferences continue to evolve, the market is expected to witness sustained growth across regions and product categories.

With ongoing advancements and rising adoption, gluten-free products are set to become a mainstream choice in global food consumption.

Explore Adjacent Markets

• Clean Label Ingredients Market
• Food Coating Market
• Food & Beverage Processing Equipment Market

CONTACT: About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook . Contact: Mr. Rohan Salgarkar MarketsandMarkets™ INC. 1615 South Congress Ave. Suite 103, Delray Beach, FL 33445 USA: +1-888-600-6441 Email: sales@marketsandmarkets.com Visit Our Website: https://www.marketsandmarkets.com/

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. DailyIndiaNews.com takes no editorial responsibility for the same.

Austin, April 30, 2026 (GLOBE NEWSWIRE) — The Pulp and Paper Market was valued at USD 363.41 billion in 2025 and is expected to reach USD 428.87 billion by 2035, growing at a CAGR of 1.67% from 2026 to 2035.

The Pulp and Paper Market is growing due to increasing demand for packaging, tissue, and specialty paper driven by e-commerce, retail, and hygiene sectors. Growth is aided by rising urbanization, industrialization, and paper consumption in emerging economies.

Download PDF Sample of Pulp and Paper Market @ https://www.snsinsider.com/sample-request/8953 

The U.S. Pulp and Paper Market was valued at USD 65.41 billion in 2025 and is expected to reach USD 73.77 billion by 2035, growing at a CAGR of 1.21% from 2026 to 2035. The growing need for packaging, tissue, and specialty paper; increased e-commerce activity; adoption of sustainable paper; and technological developments in production and recycling processes across industrial and consumer sectors are all contributing factors to the growth of the U.S. pulp and paper market.

Rapid Growth in Packaging and Tissue Demand to Boost Market Growth Globally

The need for packaging paper and tissue goods is being driven by an increase in e-commerce, urbanization, and disposable income. To increase production, industries are switching to sustainable paper alternatives in place of plastics. In industries including food service, medicine, and hygiene products, specialty sheets are becoming more popular. The efficiency and quality of production are improved by technological advancements in the pulping, bleaching, and finishing processes. Growth is supported by recycling programs and laws that promote environmentally friendly packaging. Over the course of the forecast period, the global pulp and paper market is expected to grow steadily due to ongoing industrialization and growing consumer awareness of biodegradable alternatives.

Segmentation Analysis:

By Raw Material

Wood-Based Pulp dominated with 57% share in 2025 due to its abundant availability, high-quality fiber, and strong demand from packaging, printing, and tissue industries. Recycled Paper segment is expected to grow at the fastest CAGR from 2026-2035 due to increasing environmental awareness, rising demand for sustainable packaging, and regulatory support for eco-friendly materials.

By Manufacturing Process

Chemical Pulping dominated with 52% share in 2025 as it offers high-strength fibers, consistent quality, and efficiency for large-scale paper production. Recycled Fiber Processing segment is expected to grow at the fastest CAGR from 2026-2035 due to increasing focus on sustainability and circular economy practices.

By Product Type

Packaging Paper dominated with 38% share in 2025 and is also expected to grow at the fastest CAGR from 2026-2035 due to high demand from e-commerce, food and beverage, and consumer goods industries.

By Application

Packaging dominated with 42% share in 2025 and is also segment is expected to grow at the fastest CAGR from 2026-2035 as industries increasingly rely on paper-based materials for shipping, storage, and product protection.

If You Need Any Customization on Pulp and Paper Market Report, Inquire Now @ https://www.snsinsider.com/enquiry/8953

Regional Insights:

Due to fast industrialization, urbanization, and the growth of the packaging and printing industries, Asia Pacific dominated the pulp and paper market in 2025 with the largest revenue share of almost 49%. Market adoption is further fueled by strong demand from the publishing, FMCG, and e-commerce sectors, a plentiful supply of raw materials, and supporting government regulations for sustainable paper manufacturing.

North America in the Pulp and Paper Market is witnessing steady growth due to established industrial and packaging sectors. High demand for printing, tissue, and specialty papers, coupled with adoption of advanced manufacturing technologies and sustainable practices, supports market expansion. 

Key Companies:

• International Paper Company
• Stora Enso Oyj
• UPM-Kymmene Corporation
• Suzano S.A.
• Nine Dragons Paper Holdings Limited
• Oji Holdings Corporation
• Smurfit Kappa Group
• Kimberly-Clark Corporation
• DS Smith Plc
• Mondi Group plc
• Nippon Paper Industries Co., Ltd.
• WestRock Company
• Packaging Corporation of America
• Sappi Limited
• Resolute Forest Products Inc.
• Daio Paper Corporation
• Georgia-Pacific LLC
• Lee & Man Paper Manufacturing Ltd
• Shandong Chenming Paper Holdings Limited
• Norske Skog ASA

Recent Developments:

2025: Stora Enso launched UKP Nova E, an unbleached kraft pulp grade designed for electrical insulation papers, offering low conductivity and high mechanical strength with a ~30% lower carbon footprint than bleached alternatives. 

2025: Suzano co-launched the “World Environment Rare Animal Species Series” carbon-neutral notebook in Chengdu, China, certified under ISO 14068-1. The notebook is made from 100% virgin eucalyptus pulp and maintains carbon neutrality across its full life cycle.

Buy Full Research Report on Pulp and Paper Market 2026-2035 @ https://www.snsinsider.com/checkout/8953 

Exclusive Sections of the Report (The USPs):

• Production Efficiency & Yield Metrics – helps you evaluate manufacturing performance through capacity utilization, in-house vs. outsourced production, and process efficiency benchmarks.
• Raw Material Sourcing & Supply Chain Insights – helps you understand sourcing dependencies, lead times, pricing trends, and supply chain bottlenecks across key regions.
• Energy & Environmental Performance Metrics – helps you assess sustainability through energy consumption, renewable energy adoption, water usage, and emissions per production unit.
• Product Mix & Application Analysis – helps you identify demand distribution across paper grades, applications, and the growing adoption of recycled and eco-friendly products.
• Pricing & Global Trade Analysis – helps you track pricing trends, regional price volatility, and import-export dynamics shaping the competitive market landscape.

Read Other Related Reports:

Paper Chemicals Market

Paper & Paperboard Packaging Market

Nanocellulose Market

Synthetic Paper Market

Advanced Process Control Market

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

CONTACT: Rohan Jadhav - Principal Consultant Phone: +1-315-961-9094 (US)

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. DailyIndiaNews.com takes no editorial responsibility for the same.

Austin, April 30, 2026 (GLOBE NEWSWIRE) — According to SNS Insider, The Wound Debridement Market size is valued at USD 5.16 Billion in 2025 and is projected to reach USD 9.58 Billion by 2035, growing at a CAGR of 6.42% during the forecast period of 2026–2035.

Growing diabetes-related problems, the incidence of chronic wounds, and the increasing use of enzymatic and ultrasonic debridement procedures are the main factors driving market expansion.

Get a Sample Report of Wound Debridement Market Growth Strategy @ https://www.snsinsider.com/sample-request/10138

The U.S. Wound Debridement Market is projected to grow from USD 1.70 Billion in 2025 to USD 2.96 Billion by 2035, at a CAGR of 5.73%.

Increased acceptance of debridement technologies, such as enzymatic and ultrasonic debridement, a greater emphasis on quicker healing times and more efficient infection control, and an increase in the incidence rate of chronic wounds including diabetic foot ulcers and pressure wounds are all positive growth drivers for the industry.

Rising Prevalence of Chronic Wounds and Diabetic Foot Ulcers to Propel Market Growth Globally

When compared to traditional surgical treatments, remarkable advancements have been made in enzyme debridement, ultrasound debridement, and hydro-surgery debridement technologies to improve accuracy, reduce tissue damage, and speed the healing process. Modern wound care materials, such as hydrogels, bioactive polymers, and antimicrobial dressings, are being used more frequently, which is helping to achieve faster tissue regeneration and increased efficacy in clinical settings.

Wound Debridement Control Market Segmentation Analysis:

By Method

Surgical / Sharp Debridement held the largest market share of 35.45% in 2025 due to its strong clinical reliability, rapid removal of necrotic tissue, and widespread adoption in hospital-based wound management protocols. Biological Debridement is expected to grow at the fastest CAGR of 9.80% during 2026–2035 driven by increasing adoption of maggot-based therapy globally.

By Wound Type

Chronic Wounds dominated with 62.45% market share in 2025 due to the prevalence of diabetic foot ulcers, pressure ulcers, and venous leg ulcers, which require regular debridement procedures. Chronic Wounds are expected to grow at the fastest CAGR of 6.55% during 2026–2035 due to the growing number of patients globally.  

By End User

Hospitals held the largest share of 51.85% in 2025 owing to higher patient influx, presence of wound care facilities, and a preference for surgical debridement methods. Home Healthcare Settings are expected to grow at the fastest CAGR of 7.51% during 2026–2035 owing to the trend towards decentralization of care and rising number of elderly patients globally.

By Product Type

Debridement Devices dominated with 34.21% market share in 2025 owing to the widespread application of surgical devices, mechanical devices, and energy-based devices during wound care treatments. Debridement Pads & Dressings are expected to grow at the fastest CAGR of 12.64% during 2026–2035 due to an increasing requirement for innovative consumables for wound care management that maintain proper moisture content globally.

For an In-Depth Strategic Briefing with Our Research Team, Connect Now @ https://www.snsinsider.com/request-analyst/10138

Wound Debridement Control Market Regional Insights:

Due to its highly developed healthcare infrastructure, well-established wound care industry ecosystem, and high rates of chronic wounds such diabetic foot ulcers and pressure sores, the North American wound debridement market is dominated, with a 40.54% share in 2025.

The fastest-growing region is the Asia-Pacific Wound Debridement Market, which is expected to develop at a 7.55% CAGR from 2026 to 2035. The main causes are the rising incidence of diabetic ulcers, the aging population, and the quick expansion of emerging economies’ healthcare systems.

Major Players Analysis Listed in the Wound Debridement Control Market Report:

• Smith & Nephew plc
• Mölnlycke Health Care AB
• ConvaTec Group plc
• Coloplast A/S
• B. Braun Melsungen AG
• 3M Company
• Integra LifeSciences Holdings Corporation
• Medtronic plc
• Cardinal Health Inc.
• Medline Industries Inc.
• Paul Hartmann AG (HARTMANN Group)
• Lohmann & Rauscher GmbH & Co. KG
• Organogenesis Holdings Inc.
• Baxter International Inc.
• Zimmer Biomet Holdings Inc.
• Urgo Medical
• Essity AB
• MiMedx Group Inc.
• Advanced Medical Solutions Group plc
• Hollister Incorporated

Wound Debridement Control Market Recent Developments:

• In March 2025, Smith & Nephew advanced its wound care portfolio by expanding its enzymatic debridement and negative pressure wound therapy integration solutions, strengthening clinical efficiency in chronic wound management pathways.
• In February 2025, Mölnlycke Health Care expanded its advanced wound care portfolio by enhancing its antimicrobial and moisture-balancing dressing technologies aimed at improving debridement efficiency and accelerating chronic wound healing outcomes.

Purchase Comprehensive Wound Debridement Market Report – Single User PDF @ https://www.snsinsider.com/checkout/10138

Exclusive Sections of the Report (The USPs):

• CLINICAL ADOPTION & PROCEDURE UTILIZATION METRICS – helps you understand the adoption of surgical vs. advanced debridement techniques, procedure volumes, and the shift toward outpatient and home-based care settings.
• TREATMENT OUTCOMES & CLINICAL EFFICIENCY INSIGHTS – helps you evaluate healing timelines, infection control success, tissue regeneration rates, and reduction in hospital stays driven by advanced debridement methods.
• TECHNOLOGY PENETRATION & INNOVATION TRENDS – helps you track the adoption of energy-assisted systems, minimally invasive tools, enzyme-based solutions, and AI-enabled wound care technologies.
• CHRONIC WOUND MANAGEMENT & DEMAND DRIVERS – helps you identify the impact of rising chronic conditions, aging population, and repeated debridement needs on overall market demand.
• CARE DELIVERY & MARKET SHIFT ANALYSIS – helps you assess changing preferences between hospital and outpatient care, regional demand variations, and the growing need for cost-effective home healthcare solutions.

Wound Debridement Market Report Scope

Rising Demand for Wound Debridement Market Data, Our Full Report Trend Analysis @ https://www.snsinsider.com/reports/wound-debridement-market-10138

Other Related Report:

Anti-Biofilm Wound Dressing Market

Wound Care Biologics Market

Wound Cleanser Products Market

Biosimilars Market

Cell & Gene Therapy Manufacturing Services Market

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

CONTACT: Contact Data Contact Us: Rohan Jadhav - Principal Consultant Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. DailyIndiaNews.com takes no editorial responsibility for the same.